Patent details

Basic Information

Publication number:

EP2114367

PCT Application Number:

PCT/US/2007/003285

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP077501534

PCT Publication Number:

WO/2008/097220

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

OLOPATADINE FORMULATIONS FOR TOPICAL NASAL ADMINISTRATION

French Title of Invention:

FORMULATIONS À BASE D'OLOPATADINE POUR ADMINISTRATION NASALE TOPIQUE

German Title of Invention:

FORMULIERUNGEN VON OLOPATADIN ZUR TOPISCHEN NASALEN VERABREICHUNG

SPC Number:

Dates

Filing date:

07/02/2007

Grant date:

04/11/2015

EP Publication Date:

04/11/2015

PCT Publication Date:

14/08/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/11/2009

EP B1 Publication Date:

04/11/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

07/02/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/12/2019

 

 

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

History of Owners

From:

12/12/2019

To:

12/12/2019

Name:

Alcon Pharmaceuticals Ltd.

Address:

Rue Louis-d'Affry 6, 1701 Fribourg, Switzerland (CH)

From:

07/02/2007

To:

12/12/2019

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

HAN Wesley, Wehsin

Address:

United States (US)

2

Name:

SINGH Onkar, N.

Address:

United States (US)

3

Name:

WALL G., Michael

Address:

United States (US)

4

Name:

CHOWHAN Masood, A.

Address:

United States (US)

5

Name:

JANI Rajni

Address:

United States (US)

Classification

Main IPC Class:

A61K 9/00;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2020/01

Publication date:

13/01/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2020/01

Publication date:

13/01/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000463A

Date Registered:

12/12/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Alcon Pharmaceuticals Ltd.

Address:

Rue Louis-d'Affry 6, 1701 Fribourg, Switzerland (CH)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000463B

Date Registered:

12/12/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

29/01/2026

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
12/12/2019	Request For Change	7
24/12/2019	Outgoing Correspondence	1